• SkinHealth Systems received Nasdaq notice May 8, 2026 for failing to meet Capital Market minimum bid price rule 5550(a)(2) following 30 straight business days below USD 1 from March 26, 2026 through May 7, 2026.
• Shares continue trading under symbol SKIN, with 180-day window until Nov. 4, 2026 to regain compliance via bid price at or above USD 1 for at least 10 consecutive business days.
• Failure to cure by deadline could trigger delisting process, with potential eligibility for a second 180-day cure period if other listing standards are met.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Skinhealth Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-034101), on May 12, 2026, and is solely responsible for the information contained therein.